|
Market Closed -
NYSE
23:00:00 21/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.100 USD | -1.79% |
|
+5.77% | -19.12% |
| 08-15 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-15 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
| Market Cap | 34.59M 29.63M 27.72M 25.37M 47.62M 3.31B 48.25M 328M 128M 1.66B 130M 127M 5.5B | P/E 2026 * |
7.86x | P/E 2027 * | -1.63x |
|---|---|---|---|---|---|
| Enterprise Value | 34.59M 29.63M 27.72M 25.37M 47.62M 3.31B 48.25M 328M 128M 1.66B 130M 127M 5.5B | EV / Sales 2026 * |
2.96x | EV / Sales 2027 * | - |
| Free-Float |
97.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.79% | ||
| 1 week | +5.77% | ||
| Current month | +31.44% | ||
| 1 month | +22.22% | ||
| 3 months | -6.78% | ||
| 6 months | +3.77% | ||
| Current year | -19.12% |
| 1 week | 1.03 |  | 1.15 |
| 1 month | 0.74 | | 1.15 |
| Current year | 0.74 | | 1.53 |
| 1 year | 0.74 | | 1.81 |
| 3 years | 0.74 | | 10.24 |
| 5 years | 0.74 | | 15.12 |
| 10 years | 0.74 | | 64.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 09/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 01/01/2008 |
Sandesh Seth
CHM | Chairman | 62 | 01/10/2013 |
| Director/Board Member | 68 | 08/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/18/25 A | Tax | Chief Executive Officer | 120,900 | 0.3876% | ||
| 3/31/25 A | Issuer sale | Chief Financial Officer | 706,588 | 2.2650% | ||
| 3/31/25 A | Issuer sale | Chief Executive Officer | 2,385,976 | 7.6484% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | +5.77% | -35.67% | -81.70% | 34.59M | |
| -3.00% | +2.27% | +77.60% | +109.33% | 72.12B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 65.85B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 29.28B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.47B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 26.7B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 20.06B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 18.22B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.4B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.4B | |
| Average | +0.95% | +8.10% | +50.38% | +168.97% | 28.95B | |
| Weighted average by Cap. | +0.74% | +9.48% | +59.03% | +157.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11.67M 9.99M 9.35M 8.56M 16.06M 1.12B 16.28M 110M 43.08M 561M 43.81M 42.85M 1.85B | - |
| Net income | 4.91M 4.2M 3.93M 3.6M 6.76M 469M 6.85M 46.46M 18.12M 236M 18.42M 18.02M 780M | -31.71M -27.16M -25.41M -23.26M -43.66M -3.03B -44.23M -300M -117M -1.52B -119M -116M -5.04B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | $1.100 | -1.79% | 143,919 |
| 20/08/26 | $1.120 | -0.88% | 121,416 |
| 19/08/26 | $1.130 | +4.63% | 183,406 |
| 18/08/26 | $1.080 | +2.86% | 211,197 |
| 17/08/26 | $1.050 | +0.96% | 344,942 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions
